Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Code Context


        trigger_error($message, E_USER_DEPRECATED);

    }
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.'
$stackFrame = (int) 1
$trace = [
	(int) 0 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php',
		'line' => (int) 2421,
		'function' => 'deprecationWarning',
		'args' => [
			(int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.'
		]
	],
	(int) 1 => [
		'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
		'line' => (int) 73,
		'function' => 'offsetGet',
		'class' => 'Cake\Http\ServerRequest',
		'object' => object(Cake\Http\ServerRequest) {},
		'type' => '->',
		'args' => [
			(int) 0 => 'catslug'
		]
	],
	(int) 2 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php',
		'line' => (int) 610,
		'function' => 'printArticle',
		'class' => 'App\Controller\ArtileDetailController',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 3 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 120,
		'function' => 'invokeAction',
		'class' => 'Cake\Controller\Controller',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 4 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 94,
		'function' => '_invoke',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(App\Controller\ArtileDetailController) {}
		]
	],
	(int) 5 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php',
		'line' => (int) 235,
		'function' => 'dispatch',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 6 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Http\BaseApplication',
		'object' => object(App\Application) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 7 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php',
		'line' => (int) 162,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 8 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\RoutingMiddleware',
		'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 9 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php',
		'line' => (int) 88,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 10 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\AssetMiddleware',
		'object' => object(Cake\Routing\Middleware\AssetMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 11 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php',
		'line' => (int) 96,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 12 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware',
		'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 13 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 51,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 14 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php',
		'line' => (int) 98,
		'function' => 'run',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\MiddlewareQueue) {},
			(int) 1 => object(Cake\Http\ServerRequest) {},
			(int) 2 => object(Cake\Http\Response) {}
		]
	],
	(int) 15 => [
		'file' => '/home/brlfuser/public_html/webroot/index.php',
		'line' => (int) 39,
		'function' => 'run',
		'class' => 'Cake\Http\Server',
		'object' => object(Cake\Http\Server) {},
		'type' => '->',
		'args' => []
	]
]
$frame = [
	'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
	'line' => (int) 73,
	'function' => 'offsetGet',
	'class' => 'Cake\Http\ServerRequest',
	'object' => object(Cake\Http\ServerRequest) {
		trustProxy => false
		[protected] params => [
			[maximum depth reached]
		]
		[protected] data => [[maximum depth reached]]
		[protected] query => [[maximum depth reached]]
		[protected] cookies => [
			[maximum depth reached]
		]
		[protected] _environment => [
			[maximum depth reached]
		]
		[protected] url => 'latest-news-updates/govt-caps-prices-of-new-drugs-to-treat-diabetes-hypertension-sushmi-dey-4677687/print'
		[protected] base => ''
		[protected] webroot => '/'
		[protected] here => '/latest-news-updates/govt-caps-prices-of-new-drugs-to-treat-diabetes-hypertension-sushmi-dey-4677687/print'
		[protected] trustedProxies => [[maximum depth reached]]
		[protected] _input => null
		[protected] _detectors => [
			[maximum depth reached]
		]
		[protected] _detectorCache => [
			[maximum depth reached]
		]
		[protected] stream => object(Zend\Diactoros\PhpInputStream) {}
		[protected] uri => object(Zend\Diactoros\Uri) {}
		[protected] session => object(Cake\Http\Session) {}
		[protected] attributes => [[maximum depth reached]]
		[protected] emulatedAttributes => [
			[maximum depth reached]
		]
		[protected] uploadedFiles => [[maximum depth reached]]
		[protected] protocol => null
		[protected] requestTarget => null
		[private] deprecatedProperties => [
			[maximum depth reached]
		]
	},
	'type' => '->',
	'args' => [
		(int) 0 => 'catslug'
	]
]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 73
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98

Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Code Context


        trigger_error($message, E_USER_DEPRECATED);

    }
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.'
$stackFrame = (int) 1
$trace = [
	(int) 0 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php',
		'line' => (int) 2421,
		'function' => 'deprecationWarning',
		'args' => [
			(int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.'
		]
	],
	(int) 1 => [
		'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
		'line' => (int) 74,
		'function' => 'offsetGet',
		'class' => 'Cake\Http\ServerRequest',
		'object' => object(Cake\Http\ServerRequest) {},
		'type' => '->',
		'args' => [
			(int) 0 => 'artileslug'
		]
	],
	(int) 2 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php',
		'line' => (int) 610,
		'function' => 'printArticle',
		'class' => 'App\Controller\ArtileDetailController',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 3 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 120,
		'function' => 'invokeAction',
		'class' => 'Cake\Controller\Controller',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 4 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 94,
		'function' => '_invoke',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(App\Controller\ArtileDetailController) {}
		]
	],
	(int) 5 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php',
		'line' => (int) 235,
		'function' => 'dispatch',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 6 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Http\BaseApplication',
		'object' => object(App\Application) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 7 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php',
		'line' => (int) 162,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 8 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\RoutingMiddleware',
		'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 9 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php',
		'line' => (int) 88,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 10 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\AssetMiddleware',
		'object' => object(Cake\Routing\Middleware\AssetMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 11 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php',
		'line' => (int) 96,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 12 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware',
		'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 13 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 51,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 14 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php',
		'line' => (int) 98,
		'function' => 'run',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\MiddlewareQueue) {},
			(int) 1 => object(Cake\Http\ServerRequest) {},
			(int) 2 => object(Cake\Http\Response) {}
		]
	],
	(int) 15 => [
		'file' => '/home/brlfuser/public_html/webroot/index.php',
		'line' => (int) 39,
		'function' => 'run',
		'class' => 'Cake\Http\Server',
		'object' => object(Cake\Http\Server) {},
		'type' => '->',
		'args' => []
	]
]
$frame = [
	'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
	'line' => (int) 74,
	'function' => 'offsetGet',
	'class' => 'Cake\Http\ServerRequest',
	'object' => object(Cake\Http\ServerRequest) {
		trustProxy => false
		[protected] params => [
			[maximum depth reached]
		]
		[protected] data => [[maximum depth reached]]
		[protected] query => [[maximum depth reached]]
		[protected] cookies => [
			[maximum depth reached]
		]
		[protected] _environment => [
			[maximum depth reached]
		]
		[protected] url => 'latest-news-updates/govt-caps-prices-of-new-drugs-to-treat-diabetes-hypertension-sushmi-dey-4677687/print'
		[protected] base => ''
		[protected] webroot => '/'
		[protected] here => '/latest-news-updates/govt-caps-prices-of-new-drugs-to-treat-diabetes-hypertension-sushmi-dey-4677687/print'
		[protected] trustedProxies => [[maximum depth reached]]
		[protected] _input => null
		[protected] _detectors => [
			[maximum depth reached]
		]
		[protected] _detectorCache => [
			[maximum depth reached]
		]
		[protected] stream => object(Zend\Diactoros\PhpInputStream) {}
		[protected] uri => object(Zend\Diactoros\Uri) {}
		[protected] session => object(Cake\Http\Session) {}
		[protected] attributes => [[maximum depth reached]]
		[protected] emulatedAttributes => [
			[maximum depth reached]
		]
		[protected] uploadedFiles => [[maximum depth reached]]
		[protected] protocol => null
		[protected] requestTarget => null
		[private] deprecatedProperties => [
			[maximum depth reached]
		]
	},
	'type' => '->',
	'args' => [
		(int) 0 => 'artileslug'
	]
]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 74
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98

Warning (512): Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853 [CORE/src/Http/ResponseEmitter.php, line 48]
Code Context
            if (Configure::read('debug')) {

                trigger_error($message, E_USER_WARNING);

            } else {
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f8101a446b4-trace').style.display = (document.getElementById('cakeErr67f8101a446b4-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67f8101a446b4-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f8101a446b4-code').style.display = (document.getElementById('cakeErr67f8101a446b4-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f8101a446b4-context').style.display = (document.getElementById('cakeErr67f8101a446b4-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67f8101a446b4-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67f8101a446b4-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 29630,
		&#039;title&#039; =&gt; &#039;Govt caps prices of new drugs to treat diabetes, hypertension -Sushmi Dey&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Times of India&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;NEW DELHI: &lt;/em&gt;New medicines for treatment of diabetes, hypertension and pneumonia are set to be cheaper from Diwali. Drug price regulator National Pharmaceutical Pricing Authority (NPPA) has capped prices of as many as 18 new brands of essential medicines, most of which are expected to be launched in the market within a fortnight.&lt;br /&gt;
&lt;br /&gt;
The regulator has brought these medicines under price regulation using paragraph 5 of the Drugs Price Control Order (DPCO), 2013, and has fixed their maximum retail price at the average of MRP of all medicines available in that particular therapeutic segment with at least 1% market share.&lt;br /&gt;
&lt;br /&gt;
The price fixation by NPPA includes drugs from leading pharmaceutical companies like Cipla, Merck, Franco Indian, Alembic Pharma and Unichem etc.&lt;br /&gt;
&lt;br /&gt;
In case any company fails to comply with the retail price as prescribed by the NPPA, then &amp;quot;the concerned manufacturer/ marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013&amp;quot;, the regulator said in a recent order.&lt;br /&gt;
&lt;br /&gt;
It also said if a company was planning to discontinue manufacture or sale of any of these medicine, then it would have to seek permission from the regulator six months in advance.&lt;br /&gt;
&lt;br /&gt;
The NPPA move is expected to provide consumers with more treatment options which are also cheaper for critical diseases like diabetes and hypertension. On the other hand, it is likely to keep a check on companies trying to launch price controlled formulations under new and different brands after minor changes in the composition or dosage.&lt;br /&gt;
&lt;br /&gt;
DPCO, 2013, which came into effect around May 2014, initially brought under price control 652 medicine packs based on 348 formulations of essential medicines as notified by the government under the National Pharmaceutical Pricing Policy. However, industry executives said in the past 18 months, the span of price control had expanded to entail more than 700 medicine packs.&lt;br /&gt;
&lt;br /&gt;
In its latest order, the NPPA also said if any medicine was priced lower than the ceiling fixed by the regulator, then companies selling such drugs should maintain the existing or lower retail price.&lt;br /&gt;
&lt;br /&gt;
In the last year, prices of many essential medicines have dropped significantly. The government is now also planning to review the National List of Essential Medicines, based on which price regulation is decided. It is likely the government will try to expand the list to include more new medicines under price control to make live saving drugs affordable and accessible for patients. &lt;br /&gt;
&lt;/div&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Times of India, 2 November, 2015, http://timesofindia.indiatimes.com/business/india-business/Govt-caps-prices-of-new-drugs-to-treat-diabetes-hypertension/articleshow/49623131.cms&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;govt-caps-prices-of-new-drugs-to-treat-diabetes-hypertension-sushmi-dey-4677687&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 4677687,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 29630,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | Govt caps prices of new drugs to treat diabetes, hypertension -Sushmi Dey&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;National Pharmaceutical Pricing Authority (NPPA),Access to Health,Access to Healthcare,Access to Medicines,medicine,Medicine Prices,medicines,Blood Pressure,diabetes,Hypertension&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Times of India

NEW DELHI: New medicines for treatment of diabetes, hypertension and pneumonia are set to be cheaper from Diwali. Drug price regulator National Pharmaceutical Pricing Authority (NPPA) has capped prices of as many as 18 new brands of...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;-The Times of India&lt;br /&gt;&lt;br /&gt;&lt;em&gt;NEW DELHI: &lt;/em&gt;New medicines for treatment of diabetes, hypertension and pneumonia are set to be cheaper from Diwali. Drug price regulator National Pharmaceutical Pricing Authority (NPPA) has capped prices of as many as 18 new brands of essential medicines, most of which are expected to be launched in the market within a fortnight.&lt;br /&gt;&lt;br /&gt;The regulator has brought these medicines under price regulation using paragraph 5 of the Drugs Price Control Order (DPCO), 2013, and has fixed their maximum retail price at the average of MRP of all medicines available in that particular therapeutic segment with at least 1% market share.&lt;br /&gt;&lt;br /&gt;The price fixation by NPPA includes drugs from leading pharmaceutical companies like Cipla, Merck, Franco Indian, Alembic Pharma and Unichem etc.&lt;br /&gt;&lt;br /&gt;In case any company fails to comply with the retail price as prescribed by the NPPA, then &amp;quot;the concerned manufacturer/ marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013&amp;quot;, the regulator said in a recent order.&lt;br /&gt;&lt;br /&gt;It also said if a company was planning to discontinue manufacture or sale of any of these medicine, then it would have to seek permission from the regulator six months in advance.&lt;br /&gt;&lt;br /&gt;The NPPA move is expected to provide consumers with more treatment options which are also cheaper for critical diseases like diabetes and hypertension. On the other hand, it is likely to keep a check on companies trying to launch price controlled formulations under new and different brands after minor changes in the composition or dosage.&lt;br /&gt;&lt;br /&gt;DPCO, 2013, which came into effect around May 2014, initially brought under price control 652 medicine packs based on 348 formulations of essential medicines as notified by the government under the National Pharmaceutical Pricing Policy. However, industry executives said in the past 18 months, the span of price control had expanded to entail more than 700 medicine packs.&lt;br /&gt;&lt;br /&gt;In its latest order, the NPPA also said if any medicine was priced lower than the ceiling fixed by the regulator, then companies selling such drugs should maintain the existing or lower retail price.&lt;br /&gt;&lt;br /&gt;In the last year, prices of many essential medicines have dropped significantly. The government is now also planning to review the National List of Essential Medicines, based on which price regulation is decided. It is likely the government will try to expand the list to include more new medicines under price control to make live saving drugs affordable and accessible for patients. &lt;br /&gt;&lt;/div&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 29630,
	&#039;title&#039; =&gt; &#039;Govt caps prices of new drugs to treat diabetes, hypertension -Sushmi Dey&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Times of India&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;NEW DELHI: &lt;/em&gt;New medicines for treatment of diabetes, hypertension and pneumonia are set to be cheaper from Diwali. Drug price regulator National Pharmaceutical Pricing Authority (NPPA) has capped prices of as many as 18 new brands of essential medicines, most of which are expected to be launched in the market within a fortnight.&lt;br /&gt;
&lt;br /&gt;
The regulator has brought these medicines under price regulation using paragraph 5 of the Drugs Price Control Order (DPCO), 2013, and has fixed their maximum retail price at the average of MRP of all medicines available in that particular therapeutic segment with at least 1% market share.&lt;br /&gt;
&lt;br /&gt;
The price fixation by NPPA includes drugs from leading pharmaceutical companies like Cipla, Merck, Franco Indian, Alembic Pharma and Unichem etc.&lt;br /&gt;
&lt;br /&gt;
In case any company fails to comply with the retail price as prescribed by the NPPA, then &amp;quot;the concerned manufacturer/ marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013&amp;quot;, the regulator said in a recent order.&lt;br /&gt;
&lt;br /&gt;
It also said if a company was planning to discontinue manufacture or sale of any of these medicine, then it would have to seek permission from the regulator six months in advance.&lt;br /&gt;
&lt;br /&gt;
The NPPA move is expected to provide consumers with more treatment options which are also cheaper for critical diseases like diabetes and hypertension. On the other hand, it is likely to keep a check on companies trying to launch price controlled formulations under new and different brands after minor changes in the composition or dosage.&lt;br /&gt;
&lt;br /&gt;
DPCO, 2013, which came into effect around May 2014, initially brought under price control 652 medicine packs based on 348 formulations of essential medicines as notified by the government under the National Pharmaceutical Pricing Policy. However, industry executives said in the past 18 months, the span of price control had expanded to entail more than 700 medicine packs.&lt;br /&gt;
&lt;br /&gt;
In its latest order, the NPPA also said if any medicine was priced lower than the ceiling fixed by the regulator, then companies selling such drugs should maintain the existing or lower retail price.&lt;br /&gt;
&lt;br /&gt;
In the last year, prices of many essential medicines have dropped significantly. The government is now also planning to review the National List of Essential Medicines, based on which price regulation is decided. It is likely the government will try to expand the list to include more new medicines under price control to make live saving drugs affordable and accessible for patients. &lt;br /&gt;
&lt;/div&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Times of India, 2 November, 2015, http://timesofindia.indiatimes.com/business/india-business/Govt-caps-prices-of-new-drugs-to-treat-diabetes-hypertension/articleshow/49623131.cms&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;govt-caps-prices-of-new-drugs-to-treat-diabetes-hypertension-sushmi-dey-4677687&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 4677687,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {},
		(int) 2 =&gt; object(Cake\ORM\Entity) {},
		(int) 3 =&gt; object(Cake\ORM\Entity) {},
		(int) 4 =&gt; object(Cake\ORM\Entity) {},
		(int) 5 =&gt; object(Cake\ORM\Entity) {},
		(int) 6 =&gt; object(Cake\ORM\Entity) {},
		(int) 7 =&gt; object(Cake\ORM\Entity) {},
		(int) 8 =&gt; object(Cake\ORM\Entity) {},
		(int) 9 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 29630
$metaTitle = &#039;LATEST NEWS UPDATES | Govt caps prices of new drugs to treat diabetes, hypertension -Sushmi Dey&#039;
$metaKeywords = &#039;National Pharmaceutical Pricing Authority (NPPA),Access to Health,Access to Healthcare,Access to Medicines,medicine,Medicine Prices,medicines,Blood Pressure,diabetes,Hypertension&#039;
$metaDesc = &#039;
-The Times of India

NEW DELHI: New medicines for treatment of diabetes, hypertension and pneumonia are set to be cheaper from Diwali. Drug price regulator National Pharmaceutical Pricing Authority (NPPA) has capped prices of as many as 18 new brands of...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;-The Times of India&lt;br /&gt;&lt;br /&gt;&lt;em&gt;NEW DELHI: &lt;/em&gt;New medicines for treatment of diabetes, hypertension and pneumonia are set to be cheaper from Diwali. Drug price regulator National Pharmaceutical Pricing Authority (NPPA) has capped prices of as many as 18 new brands of essential medicines, most of which are expected to be launched in the market within a fortnight.&lt;br /&gt;&lt;br /&gt;The regulator has brought these medicines under price regulation using paragraph 5 of the Drugs Price Control Order (DPCO), 2013, and has fixed their maximum retail price at the average of MRP of all medicines available in that particular therapeutic segment with at least 1% market share.&lt;br /&gt;&lt;br /&gt;The price fixation by NPPA includes drugs from leading pharmaceutical companies like Cipla, Merck, Franco Indian, Alembic Pharma and Unichem etc.&lt;br /&gt;&lt;br /&gt;In case any company fails to comply with the retail price as prescribed by the NPPA, then &amp;quot;the concerned manufacturer/ marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013&amp;quot;, the regulator said in a recent order.&lt;br /&gt;&lt;br /&gt;It also said if a company was planning to discontinue manufacture or sale of any of these medicine, then it would have to seek permission from the regulator six months in advance.&lt;br /&gt;&lt;br /&gt;The NPPA move is expected to provide consumers with more treatment options which are also cheaper for critical diseases like diabetes and hypertension. On the other hand, it is likely to keep a check on companies trying to launch price controlled formulations under new and different brands after minor changes in the composition or dosage.&lt;br /&gt;&lt;br /&gt;DPCO, 2013, which came into effect around May 2014, initially brought under price control 652 medicine packs based on 348 formulations of essential medicines as notified by the government under the National Pharmaceutical Pricing Policy. However, industry executives said in the past 18 months, the span of price control had expanded to entail more than 700 medicine packs.&lt;br /&gt;&lt;br /&gt;In its latest order, the NPPA also said if any medicine was priced lower than the ceiling fixed by the regulator, then companies selling such drugs should maintain the existing or lower retail price.&lt;br /&gt;&lt;br /&gt;In the last year, prices of many essential medicines have dropped significantly. The government is now also planning to review the National List of Essential Medicines, based on which price regulation is decided. It is likely the government will try to expand the list to include more new medicines under price control to make live saving drugs affordable and accessible for patients. &lt;br /&gt;&lt;/div&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/govt-caps-prices-of-new-drugs-to-treat-diabetes-hypertension-sushmi-dey-4677687.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | Govt caps prices of new drugs to treat diabetes, hypertension -Sushmi Dey | Im4change.org</title>
    <meta name="description" content="
-The Times of India

NEW DELHI: New medicines for treatment of diabetes, hypertension and pneumonia are set to be cheaper from Diwali. Drug price regulator National Pharmaceutical Pricing Authority (NPPA) has capped prices of as many as 18 new brands of..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>Govt caps prices of new drugs to treat diabetes, hypertension -Sushmi Dey</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">-The Times of India<br /><br /><em>NEW DELHI: </em>New medicines for treatment of diabetes, hypertension and pneumonia are set to be cheaper from Diwali. Drug price regulator National Pharmaceutical Pricing Authority (NPPA) has capped prices of as many as 18 new brands of essential medicines, most of which are expected to be launched in the market within a fortnight.<br /><br />The regulator has brought these medicines under price regulation using paragraph 5 of the Drugs Price Control Order (DPCO), 2013, and has fixed their maximum retail price at the average of MRP of all medicines available in that particular therapeutic segment with at least 1% market share.<br /><br />The price fixation by NPPA includes drugs from leading pharmaceutical companies like Cipla, Merck, Franco Indian, Alembic Pharma and Unichem etc.<br /><br />In case any company fails to comply with the retail price as prescribed by the NPPA, then &quot;the concerned manufacturer/ marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013&quot;, the regulator said in a recent order.<br /><br />It also said if a company was planning to discontinue manufacture or sale of any of these medicine, then it would have to seek permission from the regulator six months in advance.<br /><br />The NPPA move is expected to provide consumers with more treatment options which are also cheaper for critical diseases like diabetes and hypertension. On the other hand, it is likely to keep a check on companies trying to launch price controlled formulations under new and different brands after minor changes in the composition or dosage.<br /><br />DPCO, 2013, which came into effect around May 2014, initially brought under price control 652 medicine packs based on 348 formulations of essential medicines as notified by the government under the National Pharmaceutical Pricing Policy. However, industry executives said in the past 18 months, the span of price control had expanded to entail more than 700 medicine packs.<br /><br />In its latest order, the NPPA also said if any medicine was priced lower than the ceiling fixed by the regulator, then companies selling such drugs should maintain the existing or lower retail price.<br /><br />In the last year, prices of many essential medicines have dropped significantly. The government is now also planning to review the National List of Essential Medicines, based on which price regulation is decided. It is likely the government will try to expand the list to include more new medicines under price control to make live saving drugs affordable and accessible for patients. <br /></div>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$maxBufferLength = (int) 8192
$file = '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php'
$line = (int) 853
$message = 'Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853'
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 48
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 148]
Code Context
            $response->getStatusCode(),

            ($reasonPhrase ? ' ' . $reasonPhrase : '')

        ));
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f8101a446b4-trace').style.display = (document.getElementById('cakeErr67f8101a446b4-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67f8101a446b4-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f8101a446b4-code').style.display = (document.getElementById('cakeErr67f8101a446b4-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f8101a446b4-context').style.display = (document.getElementById('cakeErr67f8101a446b4-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67f8101a446b4-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67f8101a446b4-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 29630,
		&#039;title&#039; =&gt; &#039;Govt caps prices of new drugs to treat diabetes, hypertension -Sushmi Dey&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Times of India&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;NEW DELHI: &lt;/em&gt;New medicines for treatment of diabetes, hypertension and pneumonia are set to be cheaper from Diwali. Drug price regulator National Pharmaceutical Pricing Authority (NPPA) has capped prices of as many as 18 new brands of essential medicines, most of which are expected to be launched in the market within a fortnight.&lt;br /&gt;
&lt;br /&gt;
The regulator has brought these medicines under price regulation using paragraph 5 of the Drugs Price Control Order (DPCO), 2013, and has fixed their maximum retail price at the average of MRP of all medicines available in that particular therapeutic segment with at least 1% market share.&lt;br /&gt;
&lt;br /&gt;
The price fixation by NPPA includes drugs from leading pharmaceutical companies like Cipla, Merck, Franco Indian, Alembic Pharma and Unichem etc.&lt;br /&gt;
&lt;br /&gt;
In case any company fails to comply with the retail price as prescribed by the NPPA, then &amp;quot;the concerned manufacturer/ marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013&amp;quot;, the regulator said in a recent order.&lt;br /&gt;
&lt;br /&gt;
It also said if a company was planning to discontinue manufacture or sale of any of these medicine, then it would have to seek permission from the regulator six months in advance.&lt;br /&gt;
&lt;br /&gt;
The NPPA move is expected to provide consumers with more treatment options which are also cheaper for critical diseases like diabetes and hypertension. On the other hand, it is likely to keep a check on companies trying to launch price controlled formulations under new and different brands after minor changes in the composition or dosage.&lt;br /&gt;
&lt;br /&gt;
DPCO, 2013, which came into effect around May 2014, initially brought under price control 652 medicine packs based on 348 formulations of essential medicines as notified by the government under the National Pharmaceutical Pricing Policy. However, industry executives said in the past 18 months, the span of price control had expanded to entail more than 700 medicine packs.&lt;br /&gt;
&lt;br /&gt;
In its latest order, the NPPA also said if any medicine was priced lower than the ceiling fixed by the regulator, then companies selling such drugs should maintain the existing or lower retail price.&lt;br /&gt;
&lt;br /&gt;
In the last year, prices of many essential medicines have dropped significantly. The government is now also planning to review the National List of Essential Medicines, based on which price regulation is decided. It is likely the government will try to expand the list to include more new medicines under price control to make live saving drugs affordable and accessible for patients. &lt;br /&gt;
&lt;/div&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Times of India, 2 November, 2015, http://timesofindia.indiatimes.com/business/india-business/Govt-caps-prices-of-new-drugs-to-treat-diabetes-hypertension/articleshow/49623131.cms&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;govt-caps-prices-of-new-drugs-to-treat-diabetes-hypertension-sushmi-dey-4677687&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 4677687,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 29630,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | Govt caps prices of new drugs to treat diabetes, hypertension -Sushmi Dey&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;National Pharmaceutical Pricing Authority (NPPA),Access to Health,Access to Healthcare,Access to Medicines,medicine,Medicine Prices,medicines,Blood Pressure,diabetes,Hypertension&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Times of India

NEW DELHI: New medicines for treatment of diabetes, hypertension and pneumonia are set to be cheaper from Diwali. Drug price regulator National Pharmaceutical Pricing Authority (NPPA) has capped prices of as many as 18 new brands of...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;-The Times of India&lt;br /&gt;&lt;br /&gt;&lt;em&gt;NEW DELHI: &lt;/em&gt;New medicines for treatment of diabetes, hypertension and pneumonia are set to be cheaper from Diwali. Drug price regulator National Pharmaceutical Pricing Authority (NPPA) has capped prices of as many as 18 new brands of essential medicines, most of which are expected to be launched in the market within a fortnight.&lt;br /&gt;&lt;br /&gt;The regulator has brought these medicines under price regulation using paragraph 5 of the Drugs Price Control Order (DPCO), 2013, and has fixed their maximum retail price at the average of MRP of all medicines available in that particular therapeutic segment with at least 1% market share.&lt;br /&gt;&lt;br /&gt;The price fixation by NPPA includes drugs from leading pharmaceutical companies like Cipla, Merck, Franco Indian, Alembic Pharma and Unichem etc.&lt;br /&gt;&lt;br /&gt;In case any company fails to comply with the retail price as prescribed by the NPPA, then &amp;quot;the concerned manufacturer/ marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013&amp;quot;, the regulator said in a recent order.&lt;br /&gt;&lt;br /&gt;It also said if a company was planning to discontinue manufacture or sale of any of these medicine, then it would have to seek permission from the regulator six months in advance.&lt;br /&gt;&lt;br /&gt;The NPPA move is expected to provide consumers with more treatment options which are also cheaper for critical diseases like diabetes and hypertension. On the other hand, it is likely to keep a check on companies trying to launch price controlled formulations under new and different brands after minor changes in the composition or dosage.&lt;br /&gt;&lt;br /&gt;DPCO, 2013, which came into effect around May 2014, initially brought under price control 652 medicine packs based on 348 formulations of essential medicines as notified by the government under the National Pharmaceutical Pricing Policy. However, industry executives said in the past 18 months, the span of price control had expanded to entail more than 700 medicine packs.&lt;br /&gt;&lt;br /&gt;In its latest order, the NPPA also said if any medicine was priced lower than the ceiling fixed by the regulator, then companies selling such drugs should maintain the existing or lower retail price.&lt;br /&gt;&lt;br /&gt;In the last year, prices of many essential medicines have dropped significantly. The government is now also planning to review the National List of Essential Medicines, based on which price regulation is decided. It is likely the government will try to expand the list to include more new medicines under price control to make live saving drugs affordable and accessible for patients. &lt;br /&gt;&lt;/div&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 29630,
	&#039;title&#039; =&gt; &#039;Govt caps prices of new drugs to treat diabetes, hypertension -Sushmi Dey&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Times of India&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;NEW DELHI: &lt;/em&gt;New medicines for treatment of diabetes, hypertension and pneumonia are set to be cheaper from Diwali. Drug price regulator National Pharmaceutical Pricing Authority (NPPA) has capped prices of as many as 18 new brands of essential medicines, most of which are expected to be launched in the market within a fortnight.&lt;br /&gt;
&lt;br /&gt;
The regulator has brought these medicines under price regulation using paragraph 5 of the Drugs Price Control Order (DPCO), 2013, and has fixed their maximum retail price at the average of MRP of all medicines available in that particular therapeutic segment with at least 1% market share.&lt;br /&gt;
&lt;br /&gt;
The price fixation by NPPA includes drugs from leading pharmaceutical companies like Cipla, Merck, Franco Indian, Alembic Pharma and Unichem etc.&lt;br /&gt;
&lt;br /&gt;
In case any company fails to comply with the retail price as prescribed by the NPPA, then &amp;quot;the concerned manufacturer/ marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013&amp;quot;, the regulator said in a recent order.&lt;br /&gt;
&lt;br /&gt;
It also said if a company was planning to discontinue manufacture or sale of any of these medicine, then it would have to seek permission from the regulator six months in advance.&lt;br /&gt;
&lt;br /&gt;
The NPPA move is expected to provide consumers with more treatment options which are also cheaper for critical diseases like diabetes and hypertension. On the other hand, it is likely to keep a check on companies trying to launch price controlled formulations under new and different brands after minor changes in the composition or dosage.&lt;br /&gt;
&lt;br /&gt;
DPCO, 2013, which came into effect around May 2014, initially brought under price control 652 medicine packs based on 348 formulations of essential medicines as notified by the government under the National Pharmaceutical Pricing Policy. However, industry executives said in the past 18 months, the span of price control had expanded to entail more than 700 medicine packs.&lt;br /&gt;
&lt;br /&gt;
In its latest order, the NPPA also said if any medicine was priced lower than the ceiling fixed by the regulator, then companies selling such drugs should maintain the existing or lower retail price.&lt;br /&gt;
&lt;br /&gt;
In the last year, prices of many essential medicines have dropped significantly. The government is now also planning to review the National List of Essential Medicines, based on which price regulation is decided. It is likely the government will try to expand the list to include more new medicines under price control to make live saving drugs affordable and accessible for patients. &lt;br /&gt;
&lt;/div&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Times of India, 2 November, 2015, http://timesofindia.indiatimes.com/business/india-business/Govt-caps-prices-of-new-drugs-to-treat-diabetes-hypertension/articleshow/49623131.cms&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;govt-caps-prices-of-new-drugs-to-treat-diabetes-hypertension-sushmi-dey-4677687&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 4677687,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {},
		(int) 2 =&gt; object(Cake\ORM\Entity) {},
		(int) 3 =&gt; object(Cake\ORM\Entity) {},
		(int) 4 =&gt; object(Cake\ORM\Entity) {},
		(int) 5 =&gt; object(Cake\ORM\Entity) {},
		(int) 6 =&gt; object(Cake\ORM\Entity) {},
		(int) 7 =&gt; object(Cake\ORM\Entity) {},
		(int) 8 =&gt; object(Cake\ORM\Entity) {},
		(int) 9 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 29630
$metaTitle = &#039;LATEST NEWS UPDATES | Govt caps prices of new drugs to treat diabetes, hypertension -Sushmi Dey&#039;
$metaKeywords = &#039;National Pharmaceutical Pricing Authority (NPPA),Access to Health,Access to Healthcare,Access to Medicines,medicine,Medicine Prices,medicines,Blood Pressure,diabetes,Hypertension&#039;
$metaDesc = &#039;
-The Times of India

NEW DELHI: New medicines for treatment of diabetes, hypertension and pneumonia are set to be cheaper from Diwali. Drug price regulator National Pharmaceutical Pricing Authority (NPPA) has capped prices of as many as 18 new brands of...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;-The Times of India&lt;br /&gt;&lt;br /&gt;&lt;em&gt;NEW DELHI: &lt;/em&gt;New medicines for treatment of diabetes, hypertension and pneumonia are set to be cheaper from Diwali. Drug price regulator National Pharmaceutical Pricing Authority (NPPA) has capped prices of as many as 18 new brands of essential medicines, most of which are expected to be launched in the market within a fortnight.&lt;br /&gt;&lt;br /&gt;The regulator has brought these medicines under price regulation using paragraph 5 of the Drugs Price Control Order (DPCO), 2013, and has fixed their maximum retail price at the average of MRP of all medicines available in that particular therapeutic segment with at least 1% market share.&lt;br /&gt;&lt;br /&gt;The price fixation by NPPA includes drugs from leading pharmaceutical companies like Cipla, Merck, Franco Indian, Alembic Pharma and Unichem etc.&lt;br /&gt;&lt;br /&gt;In case any company fails to comply with the retail price as prescribed by the NPPA, then &amp;quot;the concerned manufacturer/ marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013&amp;quot;, the regulator said in a recent order.&lt;br /&gt;&lt;br /&gt;It also said if a company was planning to discontinue manufacture or sale of any of these medicine, then it would have to seek permission from the regulator six months in advance.&lt;br /&gt;&lt;br /&gt;The NPPA move is expected to provide consumers with more treatment options which are also cheaper for critical diseases like diabetes and hypertension. On the other hand, it is likely to keep a check on companies trying to launch price controlled formulations under new and different brands after minor changes in the composition or dosage.&lt;br /&gt;&lt;br /&gt;DPCO, 2013, which came into effect around May 2014, initially brought under price control 652 medicine packs based on 348 formulations of essential medicines as notified by the government under the National Pharmaceutical Pricing Policy. However, industry executives said in the past 18 months, the span of price control had expanded to entail more than 700 medicine packs.&lt;br /&gt;&lt;br /&gt;In its latest order, the NPPA also said if any medicine was priced lower than the ceiling fixed by the regulator, then companies selling such drugs should maintain the existing or lower retail price.&lt;br /&gt;&lt;br /&gt;In the last year, prices of many essential medicines have dropped significantly. The government is now also planning to review the National List of Essential Medicines, based on which price regulation is decided. It is likely the government will try to expand the list to include more new medicines under price control to make live saving drugs affordable and accessible for patients. &lt;br /&gt;&lt;/div&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/govt-caps-prices-of-new-drugs-to-treat-diabetes-hypertension-sushmi-dey-4677687.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | Govt caps prices of new drugs to treat diabetes, hypertension -Sushmi Dey | Im4change.org</title>
    <meta name="description" content="
-The Times of India

NEW DELHI: New medicines for treatment of diabetes, hypertension and pneumonia are set to be cheaper from Diwali. Drug price regulator National Pharmaceutical Pricing Authority (NPPA) has capped prices of as many as 18 new brands of..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>Govt caps prices of new drugs to treat diabetes, hypertension -Sushmi Dey</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">-The Times of India<br /><br /><em>NEW DELHI: </em>New medicines for treatment of diabetes, hypertension and pneumonia are set to be cheaper from Diwali. Drug price regulator National Pharmaceutical Pricing Authority (NPPA) has capped prices of as many as 18 new brands of essential medicines, most of which are expected to be launched in the market within a fortnight.<br /><br />The regulator has brought these medicines under price regulation using paragraph 5 of the Drugs Price Control Order (DPCO), 2013, and has fixed their maximum retail price at the average of MRP of all medicines available in that particular therapeutic segment with at least 1% market share.<br /><br />The price fixation by NPPA includes drugs from leading pharmaceutical companies like Cipla, Merck, Franco Indian, Alembic Pharma and Unichem etc.<br /><br />In case any company fails to comply with the retail price as prescribed by the NPPA, then &quot;the concerned manufacturer/ marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013&quot;, the regulator said in a recent order.<br /><br />It also said if a company was planning to discontinue manufacture or sale of any of these medicine, then it would have to seek permission from the regulator six months in advance.<br /><br />The NPPA move is expected to provide consumers with more treatment options which are also cheaper for critical diseases like diabetes and hypertension. On the other hand, it is likely to keep a check on companies trying to launch price controlled formulations under new and different brands after minor changes in the composition or dosage.<br /><br />DPCO, 2013, which came into effect around May 2014, initially brought under price control 652 medicine packs based on 348 formulations of essential medicines as notified by the government under the National Pharmaceutical Pricing Policy. However, industry executives said in the past 18 months, the span of price control had expanded to entail more than 700 medicine packs.<br /><br />In its latest order, the NPPA also said if any medicine was priced lower than the ceiling fixed by the regulator, then companies selling such drugs should maintain the existing or lower retail price.<br /><br />In the last year, prices of many essential medicines have dropped significantly. The government is now also planning to review the National List of Essential Medicines, based on which price regulation is decided. It is likely the government will try to expand the list to include more new medicines under price control to make live saving drugs affordable and accessible for patients. <br /></div>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$reasonPhrase = 'OK'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitStatusLine() - CORE/src/Http/ResponseEmitter.php, line 148
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 54
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 181]
Code Context
                    $value

                ), $first);

                $first = false;
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f8101a446b4-trace').style.display = (document.getElementById('cakeErr67f8101a446b4-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67f8101a446b4-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f8101a446b4-code').style.display = (document.getElementById('cakeErr67f8101a446b4-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f8101a446b4-context').style.display = (document.getElementById('cakeErr67f8101a446b4-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67f8101a446b4-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67f8101a446b4-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 29630,
		&#039;title&#039; =&gt; &#039;Govt caps prices of new drugs to treat diabetes, hypertension -Sushmi Dey&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Times of India&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;NEW DELHI: &lt;/em&gt;New medicines for treatment of diabetes, hypertension and pneumonia are set to be cheaper from Diwali. Drug price regulator National Pharmaceutical Pricing Authority (NPPA) has capped prices of as many as 18 new brands of essential medicines, most of which are expected to be launched in the market within a fortnight.&lt;br /&gt;
&lt;br /&gt;
The regulator has brought these medicines under price regulation using paragraph 5 of the Drugs Price Control Order (DPCO), 2013, and has fixed their maximum retail price at the average of MRP of all medicines available in that particular therapeutic segment with at least 1% market share.&lt;br /&gt;
&lt;br /&gt;
The price fixation by NPPA includes drugs from leading pharmaceutical companies like Cipla, Merck, Franco Indian, Alembic Pharma and Unichem etc.&lt;br /&gt;
&lt;br /&gt;
In case any company fails to comply with the retail price as prescribed by the NPPA, then &amp;quot;the concerned manufacturer/ marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013&amp;quot;, the regulator said in a recent order.&lt;br /&gt;
&lt;br /&gt;
It also said if a company was planning to discontinue manufacture or sale of any of these medicine, then it would have to seek permission from the regulator six months in advance.&lt;br /&gt;
&lt;br /&gt;
The NPPA move is expected to provide consumers with more treatment options which are also cheaper for critical diseases like diabetes and hypertension. On the other hand, it is likely to keep a check on companies trying to launch price controlled formulations under new and different brands after minor changes in the composition or dosage.&lt;br /&gt;
&lt;br /&gt;
DPCO, 2013, which came into effect around May 2014, initially brought under price control 652 medicine packs based on 348 formulations of essential medicines as notified by the government under the National Pharmaceutical Pricing Policy. However, industry executives said in the past 18 months, the span of price control had expanded to entail more than 700 medicine packs.&lt;br /&gt;
&lt;br /&gt;
In its latest order, the NPPA also said if any medicine was priced lower than the ceiling fixed by the regulator, then companies selling such drugs should maintain the existing or lower retail price.&lt;br /&gt;
&lt;br /&gt;
In the last year, prices of many essential medicines have dropped significantly. The government is now also planning to review the National List of Essential Medicines, based on which price regulation is decided. It is likely the government will try to expand the list to include more new medicines under price control to make live saving drugs affordable and accessible for patients. &lt;br /&gt;
&lt;/div&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Times of India, 2 November, 2015, http://timesofindia.indiatimes.com/business/india-business/Govt-caps-prices-of-new-drugs-to-treat-diabetes-hypertension/articleshow/49623131.cms&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;govt-caps-prices-of-new-drugs-to-treat-diabetes-hypertension-sushmi-dey-4677687&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 4677687,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 29630,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | Govt caps prices of new drugs to treat diabetes, hypertension -Sushmi Dey&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;National Pharmaceutical Pricing Authority (NPPA),Access to Health,Access to Healthcare,Access to Medicines,medicine,Medicine Prices,medicines,Blood Pressure,diabetes,Hypertension&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Times of India

NEW DELHI: New medicines for treatment of diabetes, hypertension and pneumonia are set to be cheaper from Diwali. Drug price regulator National Pharmaceutical Pricing Authority (NPPA) has capped prices of as many as 18 new brands of...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;-The Times of India&lt;br /&gt;&lt;br /&gt;&lt;em&gt;NEW DELHI: &lt;/em&gt;New medicines for treatment of diabetes, hypertension and pneumonia are set to be cheaper from Diwali. Drug price regulator National Pharmaceutical Pricing Authority (NPPA) has capped prices of as many as 18 new brands of essential medicines, most of which are expected to be launched in the market within a fortnight.&lt;br /&gt;&lt;br /&gt;The regulator has brought these medicines under price regulation using paragraph 5 of the Drugs Price Control Order (DPCO), 2013, and has fixed their maximum retail price at the average of MRP of all medicines available in that particular therapeutic segment with at least 1% market share.&lt;br /&gt;&lt;br /&gt;The price fixation by NPPA includes drugs from leading pharmaceutical companies like Cipla, Merck, Franco Indian, Alembic Pharma and Unichem etc.&lt;br /&gt;&lt;br /&gt;In case any company fails to comply with the retail price as prescribed by the NPPA, then &amp;quot;the concerned manufacturer/ marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013&amp;quot;, the regulator said in a recent order.&lt;br /&gt;&lt;br /&gt;It also said if a company was planning to discontinue manufacture or sale of any of these medicine, then it would have to seek permission from the regulator six months in advance.&lt;br /&gt;&lt;br /&gt;The NPPA move is expected to provide consumers with more treatment options which are also cheaper for critical diseases like diabetes and hypertension. On the other hand, it is likely to keep a check on companies trying to launch price controlled formulations under new and different brands after minor changes in the composition or dosage.&lt;br /&gt;&lt;br /&gt;DPCO, 2013, which came into effect around May 2014, initially brought under price control 652 medicine packs based on 348 formulations of essential medicines as notified by the government under the National Pharmaceutical Pricing Policy. However, industry executives said in the past 18 months, the span of price control had expanded to entail more than 700 medicine packs.&lt;br /&gt;&lt;br /&gt;In its latest order, the NPPA also said if any medicine was priced lower than the ceiling fixed by the regulator, then companies selling such drugs should maintain the existing or lower retail price.&lt;br /&gt;&lt;br /&gt;In the last year, prices of many essential medicines have dropped significantly. The government is now also planning to review the National List of Essential Medicines, based on which price regulation is decided. It is likely the government will try to expand the list to include more new medicines under price control to make live saving drugs affordable and accessible for patients. &lt;br /&gt;&lt;/div&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 29630,
	&#039;title&#039; =&gt; &#039;Govt caps prices of new drugs to treat diabetes, hypertension -Sushmi Dey&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Times of India&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;NEW DELHI: &lt;/em&gt;New medicines for treatment of diabetes, hypertension and pneumonia are set to be cheaper from Diwali. Drug price regulator National Pharmaceutical Pricing Authority (NPPA) has capped prices of as many as 18 new brands of essential medicines, most of which are expected to be launched in the market within a fortnight.&lt;br /&gt;
&lt;br /&gt;
The regulator has brought these medicines under price regulation using paragraph 5 of the Drugs Price Control Order (DPCO), 2013, and has fixed their maximum retail price at the average of MRP of all medicines available in that particular therapeutic segment with at least 1% market share.&lt;br /&gt;
&lt;br /&gt;
The price fixation by NPPA includes drugs from leading pharmaceutical companies like Cipla, Merck, Franco Indian, Alembic Pharma and Unichem etc.&lt;br /&gt;
&lt;br /&gt;
In case any company fails to comply with the retail price as prescribed by the NPPA, then &amp;quot;the concerned manufacturer/ marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013&amp;quot;, the regulator said in a recent order.&lt;br /&gt;
&lt;br /&gt;
It also said if a company was planning to discontinue manufacture or sale of any of these medicine, then it would have to seek permission from the regulator six months in advance.&lt;br /&gt;
&lt;br /&gt;
The NPPA move is expected to provide consumers with more treatment options which are also cheaper for critical diseases like diabetes and hypertension. On the other hand, it is likely to keep a check on companies trying to launch price controlled formulations under new and different brands after minor changes in the composition or dosage.&lt;br /&gt;
&lt;br /&gt;
DPCO, 2013, which came into effect around May 2014, initially brought under price control 652 medicine packs based on 348 formulations of essential medicines as notified by the government under the National Pharmaceutical Pricing Policy. However, industry executives said in the past 18 months, the span of price control had expanded to entail more than 700 medicine packs.&lt;br /&gt;
&lt;br /&gt;
In its latest order, the NPPA also said if any medicine was priced lower than the ceiling fixed by the regulator, then companies selling such drugs should maintain the existing or lower retail price.&lt;br /&gt;
&lt;br /&gt;
In the last year, prices of many essential medicines have dropped significantly. The government is now also planning to review the National List of Essential Medicines, based on which price regulation is decided. It is likely the government will try to expand the list to include more new medicines under price control to make live saving drugs affordable and accessible for patients. &lt;br /&gt;
&lt;/div&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Times of India, 2 November, 2015, http://timesofindia.indiatimes.com/business/india-business/Govt-caps-prices-of-new-drugs-to-treat-diabetes-hypertension/articleshow/49623131.cms&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;govt-caps-prices-of-new-drugs-to-treat-diabetes-hypertension-sushmi-dey-4677687&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 4677687,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {},
		(int) 2 =&gt; object(Cake\ORM\Entity) {},
		(int) 3 =&gt; object(Cake\ORM\Entity) {},
		(int) 4 =&gt; object(Cake\ORM\Entity) {},
		(int) 5 =&gt; object(Cake\ORM\Entity) {},
		(int) 6 =&gt; object(Cake\ORM\Entity) {},
		(int) 7 =&gt; object(Cake\ORM\Entity) {},
		(int) 8 =&gt; object(Cake\ORM\Entity) {},
		(int) 9 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 29630
$metaTitle = &#039;LATEST NEWS UPDATES | Govt caps prices of new drugs to treat diabetes, hypertension -Sushmi Dey&#039;
$metaKeywords = &#039;National Pharmaceutical Pricing Authority (NPPA),Access to Health,Access to Healthcare,Access to Medicines,medicine,Medicine Prices,medicines,Blood Pressure,diabetes,Hypertension&#039;
$metaDesc = &#039;
-The Times of India

NEW DELHI: New medicines for treatment of diabetes, hypertension and pneumonia are set to be cheaper from Diwali. Drug price regulator National Pharmaceutical Pricing Authority (NPPA) has capped prices of as many as 18 new brands of...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;-The Times of India&lt;br /&gt;&lt;br /&gt;&lt;em&gt;NEW DELHI: &lt;/em&gt;New medicines for treatment of diabetes, hypertension and pneumonia are set to be cheaper from Diwali. Drug price regulator National Pharmaceutical Pricing Authority (NPPA) has capped prices of as many as 18 new brands of essential medicines, most of which are expected to be launched in the market within a fortnight.&lt;br /&gt;&lt;br /&gt;The regulator has brought these medicines under price regulation using paragraph 5 of the Drugs Price Control Order (DPCO), 2013, and has fixed their maximum retail price at the average of MRP of all medicines available in that particular therapeutic segment with at least 1% market share.&lt;br /&gt;&lt;br /&gt;The price fixation by NPPA includes drugs from leading pharmaceutical companies like Cipla, Merck, Franco Indian, Alembic Pharma and Unichem etc.&lt;br /&gt;&lt;br /&gt;In case any company fails to comply with the retail price as prescribed by the NPPA, then &amp;quot;the concerned manufacturer/ marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013&amp;quot;, the regulator said in a recent order.&lt;br /&gt;&lt;br /&gt;It also said if a company was planning to discontinue manufacture or sale of any of these medicine, then it would have to seek permission from the regulator six months in advance.&lt;br /&gt;&lt;br /&gt;The NPPA move is expected to provide consumers with more treatment options which are also cheaper for critical diseases like diabetes and hypertension. On the other hand, it is likely to keep a check on companies trying to launch price controlled formulations under new and different brands after minor changes in the composition or dosage.&lt;br /&gt;&lt;br /&gt;DPCO, 2013, which came into effect around May 2014, initially brought under price control 652 medicine packs based on 348 formulations of essential medicines as notified by the government under the National Pharmaceutical Pricing Policy. However, industry executives said in the past 18 months, the span of price control had expanded to entail more than 700 medicine packs.&lt;br /&gt;&lt;br /&gt;In its latest order, the NPPA also said if any medicine was priced lower than the ceiling fixed by the regulator, then companies selling such drugs should maintain the existing or lower retail price.&lt;br /&gt;&lt;br /&gt;In the last year, prices of many essential medicines have dropped significantly. The government is now also planning to review the National List of Essential Medicines, based on which price regulation is decided. It is likely the government will try to expand the list to include more new medicines under price control to make live saving drugs affordable and accessible for patients. &lt;br /&gt;&lt;/div&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/govt-caps-prices-of-new-drugs-to-treat-diabetes-hypertension-sushmi-dey-4677687.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | Govt caps prices of new drugs to treat diabetes, hypertension -Sushmi Dey | Im4change.org</title>
    <meta name="description" content="
-The Times of India

NEW DELHI: New medicines for treatment of diabetes, hypertension and pneumonia are set to be cheaper from Diwali. Drug price regulator National Pharmaceutical Pricing Authority (NPPA) has capped prices of as many as 18 new brands of..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>Govt caps prices of new drugs to treat diabetes, hypertension -Sushmi Dey</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">-The Times of India<br /><br /><em>NEW DELHI: </em>New medicines for treatment of diabetes, hypertension and pneumonia are set to be cheaper from Diwali. Drug price regulator National Pharmaceutical Pricing Authority (NPPA) has capped prices of as many as 18 new brands of essential medicines, most of which are expected to be launched in the market within a fortnight.<br /><br />The regulator has brought these medicines under price regulation using paragraph 5 of the Drugs Price Control Order (DPCO), 2013, and has fixed their maximum retail price at the average of MRP of all medicines available in that particular therapeutic segment with at least 1% market share.<br /><br />The price fixation by NPPA includes drugs from leading pharmaceutical companies like Cipla, Merck, Franco Indian, Alembic Pharma and Unichem etc.<br /><br />In case any company fails to comply with the retail price as prescribed by the NPPA, then &quot;the concerned manufacturer/ marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013&quot;, the regulator said in a recent order.<br /><br />It also said if a company was planning to discontinue manufacture or sale of any of these medicine, then it would have to seek permission from the regulator six months in advance.<br /><br />The NPPA move is expected to provide consumers with more treatment options which are also cheaper for critical diseases like diabetes and hypertension. On the other hand, it is likely to keep a check on companies trying to launch price controlled formulations under new and different brands after minor changes in the composition or dosage.<br /><br />DPCO, 2013, which came into effect around May 2014, initially brought under price control 652 medicine packs based on 348 formulations of essential medicines as notified by the government under the National Pharmaceutical Pricing Policy. However, industry executives said in the past 18 months, the span of price control had expanded to entail more than 700 medicine packs.<br /><br />In its latest order, the NPPA also said if any medicine was priced lower than the ceiling fixed by the regulator, then companies selling such drugs should maintain the existing or lower retail price.<br /><br />In the last year, prices of many essential medicines have dropped significantly. The government is now also planning to review the National List of Essential Medicines, based on which price regulation is decided. It is likely the government will try to expand the list to include more new medicines under price control to make live saving drugs affordable and accessible for patients. <br /></div>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$cookies = []
$values = [
	(int) 0 => 'text/html; charset=UTF-8'
]
$name = 'Content-Type'
$first = true
$value = 'text/html; charset=UTF-8'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitHeaders() - CORE/src/Http/ResponseEmitter.php, line 181
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 55
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

<head>

    <link rel="canonical" href="<?php echo Configure::read('SITE_URL'); ?><?php echo $urlPrefix;?><?php echo $article_current->category->slug; ?>/<?php echo $article_current->seo_url; ?>.html"/>

    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>

$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp'
$dataForView = [
	'article_current' => object(App\Model\Entity\Article) {

		'id' => (int) 29630,
		'title' => 'Govt caps prices of new drugs to treat diabetes, hypertension -Sushmi Dey',
		'subheading' => '',
		'description' => '<div align="justify">
-The Times of India<br />
<br />
<em>NEW DELHI: </em>New medicines for treatment of diabetes, hypertension and pneumonia are set to be cheaper from Diwali. Drug price regulator National Pharmaceutical Pricing Authority (NPPA) has capped prices of as many as 18 new brands of essential medicines, most of which are expected to be launched in the market within a fortnight.<br />
<br />
The regulator has brought these medicines under price regulation using paragraph 5 of the Drugs Price Control Order (DPCO), 2013, and has fixed their maximum retail price at the average of MRP of all medicines available in that particular therapeutic segment with at least 1% market share.<br />
<br />
The price fixation by NPPA includes drugs from leading pharmaceutical companies like Cipla, Merck, Franco Indian, Alembic Pharma and Unichem etc.<br />
<br />
In case any company fails to comply with the retail price as prescribed by the NPPA, then &quot;the concerned manufacturer/ marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013&quot;, the regulator said in a recent order.<br />
<br />
It also said if a company was planning to discontinue manufacture or sale of any of these medicine, then it would have to seek permission from the regulator six months in advance.<br />
<br />
The NPPA move is expected to provide consumers with more treatment options which are also cheaper for critical diseases like diabetes and hypertension. On the other hand, it is likely to keep a check on companies trying to launch price controlled formulations under new and different brands after minor changes in the composition or dosage.<br />
<br />
DPCO, 2013, which came into effect around May 2014, initially brought under price control 652 medicine packs based on 348 formulations of essential medicines as notified by the government under the National Pharmaceutical Pricing Policy. However, industry executives said in the past 18 months, the span of price control had expanded to entail more than 700 medicine packs.<br />
<br />
In its latest order, the NPPA also said if any medicine was priced lower than the ceiling fixed by the regulator, then companies selling such drugs should maintain the existing or lower retail price.<br />
<br />
In the last year, prices of many essential medicines have dropped significantly. The government is now also planning to review the National List of Essential Medicines, based on which price regulation is decided. It is likely the government will try to expand the list to include more new medicines under price control to make live saving drugs affordable and accessible for patients. <br />
</div>',
		'credit_writer' => 'The Times of India, 2 November, 2015, http://timesofindia.indiatimes.com/business/india-business/Govt-caps-prices-of-new-drugs-to-treat-diabetes-hypertension/articleshow/49623131.cms',
		'article_img' => '',
		'article_img_thumb' => '',
		'status' => (int) 1,
		'show_on_home' => (int) 1,
		'lang' => 'EN',
		'category_id' => (int) 16,
		'tag_keyword' => '',
		'seo_url' => 'govt-caps-prices-of-new-drugs-to-treat-diabetes-hypertension-sushmi-dey-4677687',
		'meta_title' => null,
		'meta_keywords' => null,
		'meta_description' => null,
		'noindex' => (int) 0,
		'publish_date' => object(Cake\I18n\FrozenDate) {},
		'most_visit_section_id' => null,
		'article_big_img' => null,
		'liveid' => (int) 4677687,
		'created' => object(Cake\I18n\FrozenTime) {},
		'modified' => object(Cake\I18n\FrozenTime) {},
		'edate' => '',
		'tags' => [
			[maximum depth reached]
		],
		'category' => object(App\Model\Entity\Category) {},
		'[new]' => false,
		'[accessible]' => [
			[maximum depth reached]
		],
		'[dirty]' => [[maximum depth reached]],
		'[original]' => [[maximum depth reached]],
		'[virtual]' => [[maximum depth reached]],
		'[hasErrors]' => false,
		'[errors]' => [[maximum depth reached]],
		'[invalid]' => [[maximum depth reached]],
		'[repository]' => 'Articles'
	
	},
	'articleid' => (int) 29630,
	'metaTitle' => 'LATEST NEWS UPDATES | Govt caps prices of new drugs to treat diabetes, hypertension -Sushmi Dey',
	'metaKeywords' => 'National Pharmaceutical Pricing Authority (NPPA),Access to Health,Access to Healthcare,Access to Medicines,medicine,Medicine Prices,medicines,Blood Pressure,diabetes,Hypertension',
	'metaDesc' => '
-The Times of India

NEW DELHI: New medicines for treatment of diabetes, hypertension and pneumonia are set to be cheaper from Diwali. Drug price regulator National Pharmaceutical Pricing Authority (NPPA) has capped prices of as many as 18 new brands of...',
	'disp' => '<div align="justify">-The Times of India<br /><br /><em>NEW DELHI: </em>New medicines for treatment of diabetes, hypertension and pneumonia are set to be cheaper from Diwali. Drug price regulator National Pharmaceutical Pricing Authority (NPPA) has capped prices of as many as 18 new brands of essential medicines, most of which are expected to be launched in the market within a fortnight.<br /><br />The regulator has brought these medicines under price regulation using paragraph 5 of the Drugs Price Control Order (DPCO), 2013, and has fixed their maximum retail price at the average of MRP of all medicines available in that particular therapeutic segment with at least 1% market share.<br /><br />The price fixation by NPPA includes drugs from leading pharmaceutical companies like Cipla, Merck, Franco Indian, Alembic Pharma and Unichem etc.<br /><br />In case any company fails to comply with the retail price as prescribed by the NPPA, then &quot;the concerned manufacturer/ marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013&quot;, the regulator said in a recent order.<br /><br />It also said if a company was planning to discontinue manufacture or sale of any of these medicine, then it would have to seek permission from the regulator six months in advance.<br /><br />The NPPA move is expected to provide consumers with more treatment options which are also cheaper for critical diseases like diabetes and hypertension. On the other hand, it is likely to keep a check on companies trying to launch price controlled formulations under new and different brands after minor changes in the composition or dosage.<br /><br />DPCO, 2013, which came into effect around May 2014, initially brought under price control 652 medicine packs based on 348 formulations of essential medicines as notified by the government under the National Pharmaceutical Pricing Policy. However, industry executives said in the past 18 months, the span of price control had expanded to entail more than 700 medicine packs.<br /><br />In its latest order, the NPPA also said if any medicine was priced lower than the ceiling fixed by the regulator, then companies selling such drugs should maintain the existing or lower retail price.<br /><br />In the last year, prices of many essential medicines have dropped significantly. The government is now also planning to review the National List of Essential Medicines, based on which price regulation is decided. It is likely the government will try to expand the list to include more new medicines under price control to make live saving drugs affordable and accessible for patients. <br /></div>',
	'lang' => 'English',
	'SITE_URL' => 'https://im4change.in/',
	'site_title' => 'im4change',
	'adminprix' => 'admin'
]
$article_current = object(App\Model\Entity\Article) {

	'id' => (int) 29630,
	'title' => 'Govt caps prices of new drugs to treat diabetes, hypertension -Sushmi Dey',
	'subheading' => '',
	'description' => '<div align="justify">
-The Times of India<br />
<br />
<em>NEW DELHI: </em>New medicines for treatment of diabetes, hypertension and pneumonia are set to be cheaper from Diwali. Drug price regulator National Pharmaceutical Pricing Authority (NPPA) has capped prices of as many as 18 new brands of essential medicines, most of which are expected to be launched in the market within a fortnight.<br />
<br />
The regulator has brought these medicines under price regulation using paragraph 5 of the Drugs Price Control Order (DPCO), 2013, and has fixed their maximum retail price at the average of MRP of all medicines available in that particular therapeutic segment with at least 1% market share.<br />
<br />
The price fixation by NPPA includes drugs from leading pharmaceutical companies like Cipla, Merck, Franco Indian, Alembic Pharma and Unichem etc.<br />
<br />
In case any company fails to comply with the retail price as prescribed by the NPPA, then &quot;the concerned manufacturer/ marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013&quot;, the regulator said in a recent order.<br />
<br />
It also said if a company was planning to discontinue manufacture or sale of any of these medicine, then it would have to seek permission from the regulator six months in advance.<br />
<br />
The NPPA move is expected to provide consumers with more treatment options which are also cheaper for critical diseases like diabetes and hypertension. On the other hand, it is likely to keep a check on companies trying to launch price controlled formulations under new and different brands after minor changes in the composition or dosage.<br />
<br />
DPCO, 2013, which came into effect around May 2014, initially brought under price control 652 medicine packs based on 348 formulations of essential medicines as notified by the government under the National Pharmaceutical Pricing Policy. However, industry executives said in the past 18 months, the span of price control had expanded to entail more than 700 medicine packs.<br />
<br />
In its latest order, the NPPA also said if any medicine was priced lower than the ceiling fixed by the regulator, then companies selling such drugs should maintain the existing or lower retail price.<br />
<br />
In the last year, prices of many essential medicines have dropped significantly. The government is now also planning to review the National List of Essential Medicines, based on which price regulation is decided. It is likely the government will try to expand the list to include more new medicines under price control to make live saving drugs affordable and accessible for patients. <br />
</div>',
	'credit_writer' => 'The Times of India, 2 November, 2015, http://timesofindia.indiatimes.com/business/india-business/Govt-caps-prices-of-new-drugs-to-treat-diabetes-hypertension/articleshow/49623131.cms',
	'article_img' => '',
	'article_img_thumb' => '',
	'status' => (int) 1,
	'show_on_home' => (int) 1,
	'lang' => 'EN',
	'category_id' => (int) 16,
	'tag_keyword' => '',
	'seo_url' => 'govt-caps-prices-of-new-drugs-to-treat-diabetes-hypertension-sushmi-dey-4677687',
	'meta_title' => null,
	'meta_keywords' => null,
	'meta_description' => null,
	'noindex' => (int) 0,
	'publish_date' => object(Cake\I18n\FrozenDate) {},
	'most_visit_section_id' => null,
	'article_big_img' => null,
	'liveid' => (int) 4677687,
	'created' => object(Cake\I18n\FrozenTime) {},
	'modified' => object(Cake\I18n\FrozenTime) {},
	'edate' => '',
	'tags' => [
		(int) 0 => object(Cake\ORM\Entity) {},
		(int) 1 => object(Cake\ORM\Entity) {},
		(int) 2 => object(Cake\ORM\Entity) {},
		(int) 3 => object(Cake\ORM\Entity) {},
		(int) 4 => object(Cake\ORM\Entity) {},
		(int) 5 => object(Cake\ORM\Entity) {},
		(int) 6 => object(Cake\ORM\Entity) {},
		(int) 7 => object(Cake\ORM\Entity) {},
		(int) 8 => object(Cake\ORM\Entity) {},
		(int) 9 => object(Cake\ORM\Entity) {}
	],
	'category' => object(App\Model\Entity\Category) {},
	'[new]' => false,
	'[accessible]' => [
		'*' => true,
		'id' => false
	],
	'[dirty]' => [],
	'[original]' => [],
	'[virtual]' => [],
	'[hasErrors]' => false,
	'[errors]' => [],
	'[invalid]' => [],
	'[repository]' => 'Articles'

}
$articleid = (int) 29630
$metaTitle = 'LATEST NEWS UPDATES | Govt caps prices of new drugs to treat diabetes, hypertension -Sushmi Dey'
$metaKeywords = 'National Pharmaceutical Pricing Authority (NPPA),Access to Health,Access to Healthcare,Access to Medicines,medicine,Medicine Prices,medicines,Blood Pressure,diabetes,Hypertension'
$metaDesc = '
-The Times of India

NEW DELHI: New medicines for treatment of diabetes, hypertension and pneumonia are set to be cheaper from Diwali. Drug price regulator National Pharmaceutical Pricing Authority (NPPA) has capped prices of as many as 18 new brands of...'
$disp = '<div align="justify">-The Times of India<br /><br /><em>NEW DELHI: </em>New medicines for treatment of diabetes, hypertension and pneumonia are set to be cheaper from Diwali. Drug price regulator National Pharmaceutical Pricing Authority (NPPA) has capped prices of as many as 18 new brands of essential medicines, most of which are expected to be launched in the market within a fortnight.<br /><br />The regulator has brought these medicines under price regulation using paragraph 5 of the Drugs Price Control Order (DPCO), 2013, and has fixed their maximum retail price at the average of MRP of all medicines available in that particular therapeutic segment with at least 1% market share.<br /><br />The price fixation by NPPA includes drugs from leading pharmaceutical companies like Cipla, Merck, Franco Indian, Alembic Pharma and Unichem etc.<br /><br />In case any company fails to comply with the retail price as prescribed by the NPPA, then &quot;the concerned manufacturer/ marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013&quot;, the regulator said in a recent order.<br /><br />It also said if a company was planning to discontinue manufacture or sale of any of these medicine, then it would have to seek permission from the regulator six months in advance.<br /><br />The NPPA move is expected to provide consumers with more treatment options which are also cheaper for critical diseases like diabetes and hypertension. On the other hand, it is likely to keep a check on companies trying to launch price controlled formulations under new and different brands after minor changes in the composition or dosage.<br /><br />DPCO, 2013, which came into effect around May 2014, initially brought under price control 652 medicine packs based on 348 formulations of essential medicines as notified by the government under the National Pharmaceutical Pricing Policy. However, industry executives said in the past 18 months, the span of price control had expanded to entail more than 700 medicine packs.<br /><br />In its latest order, the NPPA also said if any medicine was priced lower than the ceiling fixed by the regulator, then companies selling such drugs should maintain the existing or lower retail price.<br /><br />In the last year, prices of many essential medicines have dropped significantly. The government is now also planning to review the National List of Essential Medicines, based on which price regulation is decided. It is likely the government will try to expand the list to include more new medicines under price control to make live saving drugs affordable and accessible for patients. <br /></div>'
$lang = 'English'
$SITE_URL = 'https://im4change.in/'
$site_title = 'im4change'
$adminprix = 'admin'

include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51

Govt caps prices of new drugs to treat diabetes, hypertension -Sushmi Dey

-The Times of India NEW DELHI: New medicines for treatment of diabetes, hypertension and pneumonia are set to be cheaper from Diwali. Drug price regulator National Pharmaceutical Pricing Authority (NPPA) has capped prices of as many as 18 new brands of essential medicines, most of which are expected to be launched in the market within a fortnight. The regulator has brought these medicines under price regulation using paragraph 5 of the Drugs Price Control Order (DPCO), 2013, and has fixed their maximum retail price at the average of MRP of all medicines available in that particular therapeutic segment with at least 1% market share. The price fixation by NPPA includes drugs from leading pharmaceutical companies like Cipla, Merck, Franco Indian, Alembic Pharma and Unichem etc. In case any company fails to comply with the retail price as prescribed by the NPPA, then "the concerned manufacturer/ marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013", the regulator said in a recent order. It also said if a company was planning to discontinue manufacture or sale of any of these medicine, then it would have to seek permission from the regulator six months in advance. The NPPA move is expected to provide consumers with more treatment options which are also cheaper for critical diseases like diabetes and hypertension. On the other hand, it is likely to keep a check on companies trying to launch price controlled formulations under new and different brands after minor changes in the composition or dosage. DPCO, 2013, which came into effect around May 2014, initially brought under price control 652 medicine packs based on 348 formulations of essential medicines as notified by the government under the National Pharmaceutical Pricing Policy. However, industry executives said in the past 18 months, the span of price control had expanded to entail more than 700 medicine packs. In its latest order, the NPPA also said if any medicine was priced lower than the ceiling fixed by the regulator, then companies selling such drugs should maintain the existing or lower retail price. In the last year, prices of many essential medicines have dropped significantly. The government is now also planning to review the National List of Essential Medicines, based on which price regulation is decided. It is likely the government will try to expand the list to include more new medicines under price control to make live saving drugs affordable and accessible for patients.